{"id":5412,"date":"2025-03-31T22:58:24","date_gmt":"2025-03-31T20:58:24","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/"},"modified":"2025-03-31T22:58:24","modified_gmt":"2025-03-31T20:58:24","slug":"les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/","title":{"rendered":"Les preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d’un trouble d’utilisation des opio\u00efdes"},"content":{"rendered":"
\n
\n
\n
\n<\/figure><\/div>\n<\/div>\n

Pour les patients atteints de trouble d’utilisation des opio\u00efdes (OUD), les preuves soutiennent la poursuite de la bupr\u00e9norphine pendant les \u00e9pisodes de douleur aigu\u00eb, mais les preuves globales des r\u00e9sultats de la douleur chez ces patients sont faibles, selon une revue publi\u00e9e en ligne le 18 mars dans le Annales de m\u00e9decine interne<\/i>.<\/p>\n

Michele J. Buonora, MD, de la Yale School of Medicine de New Haven, Connecticut, et ses coll\u00e8gues ont effectu\u00e9 une revue syst\u00e9matique pour examiner les avantages et les m\u00e9faits des interventions de douleur aigu\u00eb chez les patients atteints d’OUD. Au total, 17 essais, 20 \u00e9tudes d’observation contr\u00f4l\u00e9es et 78 \u00e9tudes d’observation non contr\u00f4l\u00e9es r\u00e9pondaient aux crit\u00e8res d’admissibilit\u00e9.<\/p>\n

Les chercheurs ont constat\u00e9 que sur la base d’\u00e9tudes de cohorte men\u00e9es principalement dans des contextes p\u00e9riop\u00e9ratoires, il peut y avoir une association entre l’utilisation continue de la bupr\u00e9norphine lors d’\u00e9pisodes de douleur aigu\u00eb avec des r\u00e9sultats similaires ou am\u00e9lior\u00e9s li\u00e9s \u00e0 la douleur par rapport \u00e0 l’arr\u00eat.<\/p>\n

Chez les adultes non prescrits des m\u00e9dicaments pour l’OUD, la clonidine orale, l’halop\u00e9ridol intramusculaire et le midazolam avec de la morphine intraveineuse, et la lidoca\u00efne introp\u00e9ratoire introp\u00e9ratoire peut am\u00e9liorer les r\u00e9sultats de la douleur bas\u00e9s sur des essais contr\u00f4l\u00e9s randomis\u00e9s bien conduits uniques en service d’urgence ou p\u00e9riop\u00e9ratifs; Ces r\u00e9sultats justifient une \u00e9tude plus approfondie dans diverses populations de patients. La m\u00e9thadone et l’effet des interventions sur les r\u00e9sultats de l’OUD n’ont \u00e9t\u00e9 \u00e9valu\u00e9s que dans un petit pourcentage d’\u00e9tudes.<\/p>\n

\u00ab\u00a0Les effets des interventions aigu\u00ebs de gestion de la douleur sur les r\u00e9sultats de l’OUD n’ont pas \u00e9t\u00e9 bien caract\u00e9ris\u00e9s et m\u00e9ritent une \u00e9tude urgente \u00e0 la lumi\u00e8re de la crise continue des surdoses li\u00e9es aux opio\u00efdes et d’autres pr\u00e9judices\u00a0\u00bb, \u00e9crivent les auteurs.<\/p>\n

<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

Pour les patients atteints de trouble d’utilisation des opio\u00efdes (OUD), les preuves soutiennent la poursuite<\/p>\n","protected":false},"author":1,"featured_media":5413,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[2883,101,684,56,639,16,586,528,4671,49,411,100,8,1190,2399,781],"class_list":["post-5412","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-aigues","tag-atteintes","tag-buprenorphine","tag-chez","tag-continue","tag-des","tag-douleurs","tag-dun","tag-dutilisation","tag-les","tag-opioides","tag-personnes","tag-pour","tag-preuves","tag-soutient","tag-trouble","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"\nLes preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d'un trouble d'utilisation des opio\u00efdes - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d'un trouble d'utilisation des opio\u00efdes - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"Pour les patients atteints de trouble d’utilisation des opio\u00efdes (OUD), les preuves soutiennent la poursuite\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-31T20:58:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1743454704_Les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"Les preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d’un trouble d’utilisation des opio\u00efdes\",\"datePublished\":\"2025-03-31T20:58:24+00:00\",\"dateModified\":\"2025-03-31T20:58:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/\"},\"wordCount\":366,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1743454704_Les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues.jpg\",\"keywords\":[\"aigu\u00ebs\",\"atteintes\",\"bupr\u00e9norphine\",\"chez\",\"continue\",\"des\",\"douleurs\",\"dun\",\"dutilisation\",\"Les\",\"opio\u00efdes\",\"personnes\",\"pour\",\"preuves\",\"soutient\",\"trouble\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/\",\"name\":\"Les preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d'un trouble d'utilisation des opio\u00efdes - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1743454704_Les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues.jpg\",\"datePublished\":\"2025-03-31T20:58:24+00:00\",\"dateModified\":\"2025-03-31T20:58:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1743454704_Les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1743454704_Les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Les preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d'un trouble d'utilisation des opio\u00efdes\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d’un trouble d’utilisation des opio\u00efdes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d'informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d'un trouble d'utilisation des opio\u00efdes - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/","og_locale":"fr_FR","og_type":"article","og_title":"Les preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d'un trouble d'utilisation des opio\u00efdes - RVH-Synergie.org","og_description":"Pour les patients atteints de trouble d’utilisation des opio\u00efdes (OUD), les preuves soutiennent la poursuite","og_url":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/","og_site_name":"RVH-Synergie","article_published_time":"2025-03-31T20:58:24+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1743454704_Les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"Les preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d’un trouble d’utilisation des opio\u00efdes","datePublished":"2025-03-31T20:58:24+00:00","dateModified":"2025-03-31T20:58:24+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/"},"wordCount":366,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1743454704_Les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues.jpg","keywords":["aigu\u00ebs","atteintes","bupr\u00e9norphine","chez","continue","des","douleurs","dun","dutilisation","Les","opio\u00efdes","personnes","pour","preuves","soutient","trouble"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/","url":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/","name":"Les preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d'un trouble d'utilisation des opio\u00efdes - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1743454704_Les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues.jpg","datePublished":"2025-03-31T20:58:24+00:00","dateModified":"2025-03-31T20:58:24+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1743454704_Les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1743454704_Les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues.jpg","width":1280,"height":853,"caption":"Les preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d'un trouble d'utilisation des opio\u00efdes"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/les-preuves-soutient-la-buprenorphine-continue-pour-des-douleurs-aigues-chez-les-personnes-atteintes-dun-trouble-dutilisation-des-opioides\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"Les preuves soutient la bupr\u00e9norphine continue pour des douleurs aigu\u00ebs chez les personnes atteintes d’un trouble d’utilisation des opio\u00efdes"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d'informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/5412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=5412"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/5412\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/5413"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=5412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=5412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=5412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}